Shi-Qiang Gong

Dr. Shi-Qiang Gong

Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZLZixin Li
Zixin Li
DHDanqing He
Danqing He
BGBowen Guo
Bowen Guo
ZWZekun Wang
Zekun Wang
HYHuajie Yu
Huajie Yu
Yan LiuYan Liu
Yan Liu
Infected bone defects are a major challenge in orthopedic treatment. Native bone tissue possesses an endogenous electroactive interface that induces stem cell differentiation and inhibits bacterial adhesion and activity. However, traditional bone substitutes have difficulty in reconstructing the electrical environment of bone. In this study, we develop a self-promoted electroactive mineralized scaffold (sp-EMS) that generates weak currents via spontaneous electrochemical reactions to activate voltage-gated Ca2+channels, enhance adenosine triphosphate-induced actin remodeling, and ultimately achieve osteogenic differentiation of mesenchymal stem cells by activating the BMP2/Smad5 pathway. Furthermore, we show that the electroactive interface provided by the sp-EMS inhibits bacterial adhesion and activity via electrochemical products and concomitantly generated reactive oxygen species. We find that the osteogenic and antibacterial dual functions of the sp-EMS depend on its self-promoting electrical stimulation. We demonstrate that in vivo, the sp-EMS achieves complete or nearly complete in situ infected bone healing, from a rat calvarial defect model with single bacterial infection, to a rabbit open alveolar bone defect model and a beagle dog vertical bone defect model with the complex oral bacterial microenvironment. This translational study demonstrates that the electroactive bone graft presents a promising therapeutic platform for complex defect repair.

1 September 2012 in Acta Biomaterialia
Verified
Journal Article
Closed access
Shi-Qiang GongShi-Qiang Gong
Shi-Qiang Gong
LNLi-Na Niu
Li-Na Niu
LKLisa K. Kemp
Lisa K. Kemp
CYCynthia K.Y. Yiu
Cynthia K.Y. Yiu
HRHeonjune Ryou
Heonjune Ryou
FTFranklin R. Tay
Franklin R. Tay

2 August 2012 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
LNLi‐Na Niu
Li‐Na Niu
KJKai Jiao
Kai Jiao
YQYi‐Pin Qi
Yi‐Pin Qi
SNSergey Nikonov
Sergey Nikonov
CYCynthia K. Y. Yiu
Cynthia K. Y. Yiu
FTFranklin R. Tay
Franklin R. Tay
Traditional bone regeneration strategies relied on supplementation of biomaterials constructs with stem or progenitor cells or growth factors. By contrast, cell homing strategies employ chemokines to mobilize stem or progenitor cells from host bone marrow and tissue niches to injured sites. Although silica‐based biomaterials exhibit osteogenic and angiogenic potentials, they lack cell homing capability. Stromal cell‐derived factor‐1 (SDF‐1) plays a pivotal role in mobilization and homing of stem cells to injured tissues. In this work, we demonstrated that 3‐dimensional collagen scaffolds infiltrated with intrafibrillar silica are biodegradable and highly biocompatible. They exhibit improved compressive stress‐strain responses and toughness over nonsilicified collagen scaffolds. They are osteoconductive and up‐regulate expressions of osteogenesis‐ and angiogenesis‐related genes more significantly than nonsilicified collagen scaffolds. In addition, these scaffolds reversibly bind SDF‐1α for sustained release of this chemokine, which exhibits in vitro cell homing characteristics. When implanted subcutaneously in an in vivo mouse model, SDF‐1α‐loaded silicified collagen scaffolds stimulate the formation of ectopic bone and blood capillaries within the scaffold and abrogate the need for cell seeding or supplementation of osteogenic and angiogenic growth factors. Intrafibrillar‐silicified collagen scaffolds with sustained SDF‐1α release represent a less costly and complex alternative to contemporary cell seeding approaches and provide new therapeutic options for in situ hard tissue regeneration.—Niu, L.‐N., Jiao, K., Qi, Y.‐P., Nikonov, S., Yiu, C. K. Y., Arola, D. D., Gong, S.‐Q., El‐Marakby, A., Carrilho, M. R. O., Hamrick, M. W., Hargreaves, K. M., Diogenes, A., Chen, J.‐H., Pashley, D. H., Tay, F. R. Intrafibrillar silicification of collagen scaffolds for sustained release of stem cell homing chemokine in hard tissue regeneration. FASEB J. 26, 4517–4529 (2012). www.fasebj.org

1 August 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Shi-Qiang GongShi-Qiang Gong
Shi-Qiang Gong
JEJeevani Epasinghe
Jeevani Epasinghe
FRFred Rueggeberg
Fred Rueggeberg
LNLi-Na Niu
Li-Na Niu
DMDonald Mettenberg
Donald Mettenberg
FTFranklin R. Tay
Franklin R. Tay
Global increase in patients seeking orthodontic treatment creates a demand for the use of acrylic resins in removable appliances and retainers. Orthodontic removable appliance wearers have a higher risk of oral infections that are caused by the formation of bacterial and fungal biofilms on the appliance surface. Here, we present the synthetic route for an antibacterial and antifungal organically-modified silicate (ORMOSIL) that has multiple methacryloloxy functionalities attached to a siloxane backbone (quaternary ammonium methacryloxy silicate, or QAMS). By dissolving the water-insoluble, rubbery ORMOSIL in methyl methacrylate, QAMS may be copolymerized with polymethyl methacrylate, and covalently incorporated in the pressure-processed acrylic resin. The latter demonstrated a predominantly contact-killing effect on Streptococcus mutans ATCC 36558 and Actinomyces naselundii ATCC 12104 biofilms, while inhibiting adhesion of Candida albicans ATCC 90028 on the acrylic surface. Apart from its favorable antimicrobial activities, QAMS-containing acrylic resins exhibited decreased water wettability and improved toughness, without adversely affecting the flexural strength and modulus, water sorption and solubility, when compared with QAMS-free acrylic resin. The covalently bound, antimicrobial orthodontic acrylic resin with improved toughness represents advancement over other experimental antimicrobial acrylic resin formulations, in its potential to simultaneously prevent oral infections during appliance wear, and improve the fracture resistance of those appliances.

Verified
Journal Article
Open access
PDF file
YWYaxin Wu
Yaxin Wu
XWXiangyao Wang
Xiangyao Wang
YZYuxiao Zhang
Yuxiao Zhang
ZWZhihao Wen
Zhihao Wen
YLYuanyuan Li
Yuanyuan Li
Shi-Qiang GongShi-Qiang Gong
Shi-Qiang Gong
Periodontitis is a bacteria-induced inflammatory disease characterized by the progressive destruction of periodontal supporting tissues. Periodontal ligament stem cells (PDLSCs) are capable of differentiating into osteoblasts, which is an important stem cell source for endogenous periodontal tissue regeneration. Lysine lactylation (Kla) is a novel post-translational modification of proteins that is recently thought to be associated with osteogenic differentiation. Here, we found that lactylation levels are reduced both in the periodontal tissue of rats with periodontitis and lipopolysaccharide (LPS)-stimulated human PDLSCs. Proanthocyanidins were able to promote the osteogenesis of inflamed PDLSCs by restoring lactylation levels. Mechanistically, proanthocyanidins increased lactate production and restored the lactylation levels of PDLSCs, which recovered osteogenesis of inflamed PDLSCs via the Wnt/β-catenin pathway. These results provide evidence on how epigenetic regulation by pharmacological agents influence the osteogenic phenotype of stem cells and the process of periodontal tissue repair. Our current study highlights the valuable potential of natural product proanthocyanidins in the regenerative engineering of periodontal tissues.

2 December 2016 in Scientific Reports
Verified
Journal Article
Open access
ZHZhi-Bin Huang
Zhi-Bin Huang
XSXin Shi
Xin Shi
JMJing Mao
Jing Mao
Shi-Qiang GongShi-Qiang Gong
Shi-Qiang Gong
Controlling and reducing the formation of pathogenic biofilm on tooth surface is the key to the prevention and treatment of the biofilm-associated oral diseases. Antimicrobial peptides (AMPs), considered as possible future alternatives for conventional antibiotics, have been extensively studied for the control of bacterial infection. Due to the rapid dilution and degradation by human saliva, AMP preparations designed for oral use with longer retention and higher efficacy are in urgent need. To this end, a hydroxyapatite (HAp)-binding antimicrobial peptide (HBAMP), which is based on the fusion of a specific HAp-binding heptapeptide (HBP7) domain and a broad-spectrum antimicrobial peptide (KSLW) domain, has been developed in our laboratory. HBAMP was supposed to form a contact-active antibacterial interface on tooth surface to inhibit the formation of biofilms. In this study, we investigated its binding behaviour, antibacterial activity against bacteria in both planktonic and sessile states, enzymatic stability in human saliva, and cytocompatibility to human gingival fibroblasts (HGFs). Our findings suggest that HBAMP could adsorb on tooth surface to provide effective antibacterial activity with improved retention. This study provides a proof-of-concept on using conjugated molecules to promote antibacterial efficacy by synergistically actions of HBAMP free in solution and bound on tooth surface.